참고문헌
- Jensen SA, Sorensen JB. Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine. Cancer Chemother Pharmacol 2006;58:487-493. https://doi.org/10.1007/s00280-005-0178-1
- Wacker A, Lersch C, Scherpinski U, Reindl L, Seyfarth M. High incidence of angina pectoris in patients treated with 5-fluorouracil: a planned surveillance study with 102 patients. Oncology 2003;65:108-112. https://doi.org/10.1159/000072334
- Robben NC, P ippa s AW, Moore JO. The sy nd rome of 5-fluorouracil cardiotoxicity: an elusive cardiopathy. Cancer 1993;71:493-509. https://doi.org/10.1002/1097-0142(19930115)71:2<493::AID-CNCR2820710235>3.0.CO;2-C
- Kuzel T, Esparaz B, Green D, Kies M. Thrombogenicity of intravenous 5-f luorouracil alone or in combination with cisplatin. Cancer 1990;65:885-889. https://doi.org/10.1002/1097-0142(19900215)65:4<885::AID-CNCR2820650410>3.0.CO;2-H
- Gradishar WJ, Vokes EE. 5-Fluorouracil cardiotoxicity: a critical review. Ann Oncol 1990;1:409-414. https://doi.org/10.1093/oxfordjournals.annonc.a057793
- Rezkalla S, Kloner RA, Ensley J, et al. Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study. J Clin Oncol 1989;7:509-514. https://doi.org/10.1200/JCO.1989.7.4.509
- Kleiman NS, Lehane DE, Geyer CE Jr, Pratt CM, Young JB. Prinzmetal's angina during 5-fluorouracil chemotherapy. Am J Med 1987;82:566-568. https://doi.org/10.1016/0002-9343(87)90465-7
- Patel B, Kloner RA, Ensley J, Al-Sarraf M, Kish J, Wynne J. 5-fluorouracil cardiotoxicity: left ventricular dysfunction and effect of coronary vasodilators. Am J Med Sci 1987;294:238-243. https://doi.org/10.1097/00000441-198710000-00004
- Baker WP, Dainer P, Lester WM, Marty AM, Blair TP. Ischemic chest pain after 5-fluorouracil therapy for cancer. Am J Cardiol 1986;57:497-498. https://doi.org/10.1016/0002-9149(86)90788-5
- Meydan N, Kundak I, Yavuzsen T, et al. Cardiotoxicity of de Gramont's regimen: incidence, clinical characteristics and longterm follow-up. Jpn J Clin Oncol 2005;35:265-270. https://doi.org/10.1093/jjco/hyi071
피인용 문헌
- Fluorouracil vol.1431, pp.1, 2012, https://doi.org/10.1007/s40278-012-0066-5
- A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity vol.15, pp.None, 2014, https://doi.org/10.1186/2050-6511-15-47
- Coenzyme Complex Decreased Cardiotoxicity When Combined with Chemotherapy in Treating Elderly Patients with Gastrointestinal Cancer vol.16, pp.9, 2015, https://doi.org/10.7314/apjcp.2015.16.9.4045
- Pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity vol.31, pp.4, 2012, https://doi.org/10.3904/kjim.2016.017
- 5-fluorouracil and cardiotoxicity: a review vol.10, pp.None, 2012, https://doi.org/10.1177/1758835918780140
- Mitochondrial Dynamics in Rat Heart Induced by 5-Fluorouracil vol.24, pp.None, 2012, https://doi.org/10.12659/msm.910537
- Diagnosis, Treatment, and Prevention of Cardiovascular Toxicity Related to Anti-Cancer Treatment in Clinical Practice: An Opinion Paper from the Working Group on Cardio-Oncology of the Korean Society vol.26, pp.1, 2018, https://doi.org/10.4250/jcu.2018.26.1.1
- Coronary Artery Vasospasm Induced by 5-fluorouracil: Proposed Mechanisms, Existing Management Options and Future Directions vol.14, pp.2, 2019, https://doi.org/10.15420/icr.2019.12
- Fluorouracil-induced Takotsubo cardiomyopathy causing cardiogenic shock: a case report of clinical and acute cardiac magnetic resonance imaging features vol.3, pp.4, 2012, https://doi.org/10.1093/ehjcr/ytz146
- S1-induced vasospastic angina—diagnostic utility of Holter ECG: a report of a case vol.6, pp.1, 2012, https://doi.org/10.1186/s40792-020-00975-x
- Myocardial Ischemia Induced by 5-Fluorouracil: A Prospective Electrocardiographic and Cardiac Biomarker Study vol.26, pp.3, 2012, https://doi.org/10.1002/onco.13536